Table 1:
Features |
---|
Endogenous models (GEMMs and nontargeted mutagenesis/carcinogenesis) |
Unpredictable latency periods, growth curves, tumor location, and morphology; implies regular screening for tumor detection and longitudinal monitoring for progression; more physiologic and best representing human disease |
Exogenous models or xenografts |
Predictable and reproducible, high tumor take; best for high throughput preclinical trials; less physiologic and less representative of the actual human condition |